
Danish Biotech Weekly – Week 27
Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates on clinical trials, acquisitions, insider
Home » Sector cases » Page 5

Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates on clinical trials, acquisitions, insider

Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates on clinical trials, acquisitions, insider

Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates on clinical trials, acquisitions, insider

Over the past 5 years, a large number of companies have been listed on First North Denmark. We take a closer look at what the

Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates on clinical trials, acquisitions, insider

Last week, the Danish recycling company Combineering A/S was sold to the UK-based Reconomy Group for approximately DKK 1.5 billion. Combineering is part of the

Global demand for food is growing as the global population increases year on year combined with increased consumption. Increased production is needed to meet this

Within Life Science and biotech companies, upcoming news flow in the form of price triggers is important for the development of the share price. This

The biotech companies are having difficulties in terms of stock prices, initially driven by rising interest rates and energy prices, and in terms of the

Software-as-a-Service as a growth sector did like many other sectors not avoid price drops caused by e.g. rising interest rates and geopolitical unrest. Yet 5
Kapital Partner performs or has within the last 12 months performed corporate finance, market relations, investor relations, Certified Adviser or other advisory activities for the following listed companies: NORD.investments, Biosergen, InterMail, Pila Pharma, Hypefactors, Curasight, Evaxion, Re-Match, Audientes, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.